|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
increases expression |
EXP |
Swainsonine results in increased expression of AIFM1 protein |
CTD |
PMID:33186601 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation |
ISO |
Swainsonine results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:36402259 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Atg5 |
autophagy related 5 |
multiple interactions increases expression |
ISO |
[bafilomycin A1 co-treated with Swainsonine] results in increased expression of ATG5 mRNA; [bafilomycin A1 co-treated with Swainsonine] results in increased lipidation of ATG5 protein Swainsonine results in increased expression of ATG5 mRNA; Swainsonine results in increased expression of ATG5 protein |
CTD |
PMID:36402259 |
|
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Becn1 |
beclin 1 |
multiple interactions increases expression |
EXP ISO |
[Swainsonine co-treated with bafilomycin A1] results in increased expression of BECN1 protein Swainsonine results in increased expression of BECN1 protein Swainsonine results in increased expression of BECN1 mRNA; Swainsonine results in increased expression of BECN1 protein |
CTD |
PMID:33186601 PMID:36402259 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases cleavage |
EXP |
[Swainsonine co-treated with aloxistatin] results in increased cleavage of CASP3 protein; [Swainsonine co-treated with bafilomycin A1] results in increased cleavage of CASP3 protein Swainsonine results in increased cleavage of CASP3 protein |
CTD |
PMID:33186601 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases cleavage |
EXP |
Swainsonine results in increased cleavage of CASP8 protein |
CTD |
PMID:33186601 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases cleavage multiple interactions |
EXP |
Swainsonine results in increased cleavage of CASP9 protein [Swainsonine co-treated with Sirolimus] results in increased cleavage of CASP9 protein |
CTD |
PMID:33186601 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ctsd |
cathepsin D |
decreases expression |
EXP |
Swainsonine results in decreased expression of CTSD protein |
CTD |
PMID:33186601 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
decreases phosphorylation |
ISO |
Swainsonine results in decreased phosphorylation of EIF4EBP1 protein |
CTD |
PMID:36402259 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Faslg |
Fas ligand |
increases expression |
EXP |
Swainsonine results in increased expression of FASLG protein |
CTD |
PMID:33186601 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Lamp1 |
lysosomal-associated membrane protein 1 |
multiple interactions increases expression |
ISO |
[bafilomycin A1 co-treated with Swainsonine] results in increased expression of LAMP1 mRNA; [bafilomycin A1 co-treated with Swainsonine] results in increased expression of LAMP1 protein Swainsonine results in increased expression of LAMP1 mRNA; Swainsonine results in increased expression of LAMP1 protein |
CTD |
PMID:36402259 |
|
NCBI chr16:76,355,982...76,380,700
Ensembl chr16:76,355,984...76,381,883
|
|
G |
Man2a1 |
mannosidase, alpha, class 2A, member 1 |
multiple interactions decreases expression |
ISO |
bafilomycin A1 inhibits the reaction [Swainsonine results in decreased expression of MAN2A1 mRNA] |
CTD |
PMID:36402259 |
|
NCBI chr 9:104,252,001...104,408,349
Ensembl chr 9:104,252,001...104,408,349
|
|
G |
Man2b1 |
mannosidase, alpha, class 2B, member 1 |
multiple interactions decreases expression |
ISO |
bafilomycin A1 inhibits the reaction [Swainsonine results in decreased expression of MAN2B1 mRNA] |
CTD |
PMID:36402259 |
|
NCBI chr19:23,055,092...23,074,398
Ensembl chr19:23,055,097...23,074,389
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions increases expression increases lipidation |
ISO |
[bafilomycin A1 co-treated with Swainsonine] results in increased expression of MAP1LC3B mRNA; [bafilomycin A1 co-treated with Swainsonine] results in increased lipidation of MAP1LC3B protein Swainsonine results in increased expression of MAP1LC3B mRNA Swainsonine results in increased lipidation of MAP1LC3B protein |
CTD |
PMID:36402259 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases phosphorylation |
ISO |
Swainsonine results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:36402259 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases phosphorylation |
ISO |
Swainsonine results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:36402259 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
decreases phosphorylation |
ISO |
Swainsonine results in decreased phosphorylation of MTOR protein |
CTD |
PMID:36402259 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
decreases phosphorylation |
ISO |
Swainsonine results in decreased phosphorylation of PIK3R1 protein |
CTD |
PMID:36402259 |
|
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
decreases phosphorylation |
ISO |
Swainsonine results in decreased phosphorylation of RPS6KB1 protein |
CTD |
PMID:36402259 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Sqstm1 |
sequestosome 1 |
increases expression multiple interactions |
ISO |
Swainsonine results in increased expression of SQSTM1 mRNA; Swainsonine results in increased expression of SQSTM1 protein [bafilomycin A1 co-treated with Swainsonine] results in increased expression of SQSTM1 mRNA; [bafilomycin A1 co-treated with Swainsonine] results in increased lipidation of SQSTM1 protein |
CTD |
PMID:36402259 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Tfeb |
transcription factor EB |
decreases expression |
EXP |
Swainsonine results in decreased expression of TFEB protein |
CTD |
PMID:33186601 |
|
NCBI chr 9:13,198,890...13,254,726
Ensembl chr 9:13,198,891...13,254,714
|
|
G |
Tp53 |
tumor protein p53 |
increases expression |
ISO |
Swainsonine results in increased expression of TRP53 protein |
CTD |
PMID:36402259 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|